Tenders
Oncology drug tenders in Slovakia
Oncology drug tenders in Slovakia: 55 listed on GranTender since 2024; none is open now. The median awarded contract value is about €69,000 (200 contracts with a stated value). Buyers with the most tenders: Všeobecná zdravotná poisťovňa, a. s. (15), Fakultná nemocnica s poliklinikou Žilina (13) and Národný ústav reumatických chorôb (5); suppliers with the most contract awards: MED - ART, spol. s r.o. (95), UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť (49) and BAX PHARMA, s.r.o. (20). Sources: Centrálny register zmlúv and TED. In 2025 the median contract value was €150,000; 44% of contracts drew a single bid (2.1 bids on average). Data as of 18 November 2026; updated daily.
- Tenders
- 55
- Open tenders
- 0
- Awards
- 218
- Awarded value awarded
- €83,733,134
- Awarded value framework ceiling
- €10,165,516
- Median contract value awarded
- ≈ €69,000
- Median contract value framework ceiling
- ≈ €330,000
- Average bids per contract
- 2.2
- Tenders in 2025
- 25 +47% on 2024
Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.
Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.
Open tenders
No records yet.
Latest tenders
Top buyers
- Všeobecná zdravotná poisťovňa, a. s.15
- Fakultná nemocnica s poliklinikou Žilina13
- Národný ústav reumatických chorôb5
- Ústredná Vojenská Nemocnica SNP Ružomberok - Fakultná Nemocnica4
- Fakultná nemocnica Trnava4
- Fakultná nemocnica s poliklinikou F. D. Roosevelta Banská Bystrica3
- Detská fakultná nemocnica s poliklinikou Banská Bystrica3
- Univerzitná nemocnica Martin2
- Fakultná nemocnica Trenčín2
- Špecializovaná nemocnica sv. Svorada Zobor, n.o.2
Top winners
Competition and prices
In 2025, half of the contracts were worth between €21,000 and €610,000, with a median of €150,000 (74 contracts with a stated awarded value). Contracts drew 2.1 bids on average (median 2) and 44% drew a single bid — based on 79 contracts with a known number of bids. Compared with 2024, in 2025 the median value fell 12% and the share of single-bid contracts rose from 35% to 44%. The usual procedures: open procedure (96%), negotiation without a call for competition (2%), restricted procedure (2%) — of 55 tenders with a stated procedure.
The most contracts went to MED - ART, spol. s r.o. (95), UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť (49) and BAX PHARMA, s.r.o. (20) — together 75% of all contracts.
| Year | Contracts | Median value | Middle half of values | Bids on average | Single bid |
|---|---|---|---|---|---|
| 2024 | 31 | €170,000 | €39,000 – €390,000 | 2.0 | 35% (31) |
| 2025 | 79 | €150,000 | €21,000 – €610,000 | 2.1 | 44% (79) |
| 2026 (so far) | 81 | €46,000 | €12,000 – €260,000 | 2.3 | 28% (80) |
| All years | 218 | €69,000 | €15,000 – €340,000 | 2.2 | 33% (217) |
Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.
Where you have a chance
Since 1 November 2024, 36% of the 159 contracts with a known number of bids had a single bid; the median was 2 bids. The number of bids is known for 159 of the 159 contracts from procedures with competition.
Buyers who often get few offers
The buyers below usually received one or two offers per contract — an offer from you would stand out.
| Buyer | Contracts with known bids | Median bids | Single bid |
|---|---|---|---|
| Univerzitná nemocnica Martin | 62 | 2 | 27% |
| Ústredná Vojenská Nemocnica SNP Ružomberok - Fakultná Nemocnica | 18 | 2 | 33% |
| Národný Endokrinologický a Diabetologický Ústav N. O. | 13 | 1 | 100% |
| Fakultná nemocnica s poliklinikou Žilina | 11 | 1 | 55% |
| Národný ústav reumatických chorôb | 10 | 2 | 20% |
In the last 12 months, 0 companies won their first contract in our records here — 0% of the 86 contracts (our records start on 1 January 2024).
Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.
Main CPV divisions
CPV codes of this topic
A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.
Oncology and immunomodulating drugs in neighbouring countries
Today, 65 tenders in the same niche are open in neighbouring countries.
- Czechia — 32 open today
- Ukraine — 17 open today
- Poland — 16 open today · how to bid in Poland
Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. In countries outside the EU and the EEA, the notice says who may bid. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.
Expected soon4
| Expected | Buyer | What | Why we expect it | Confidence |
|---|---|---|---|---|
| Dec 2026 – May 2027 | Špecializovaná nemocnica sv. Svorada Zobor, n.o. | Oncology and immunomodulating drugs | The current contract with MED - ART, spol. s r.o. ends on 1 June 2027 (from its stated duration); no new tender has been published yet. | high |
| Dec 2026 – Jan 2027 | Ústredná Vojenská Nemocnica SNP Ružomberok - Fakultná Nemocnica | Oncology and immunomodulating drugs | The buyer has published oncology drug tenders every year in December since 2024. The current contract with Roche Slovensko, s.r.o. ends on 21 May 2027 (from its stated duration); no new tender has been published yet. | high |
| Dec 2026 – May 2027 | Národný Endokrinologický a Diabetologický Ústav N. O. | Oncology and immunomodulating drugs | The current contract with LK1 s. r. o. ends on 10 June 2027 (from its stated duration); no new tender has been published yet. | medium |
| Jan – Jun 2027 | Detská fakultná nemocnica s poliklinikou Banská Bystrica | Oncology and immunomodulating drugs | The current contract with MED - ART, spol. s r.o. ends on 11 July 2027 (from its stated duration); no new tender has been published yet. The current contract with MED - ART, spol. s r.o. ends on 20 August 2027 (from its stated duration); no new tender has been published yet. | high |
Forecast from public data, not an announcement. Methodology.
Oncology and immunomodulating drugs by city
Oncology and immunomodulating drugs in other countries
Oncology and immunomodulating drugs across Europe
Topics in Health, medical equipment and medicines
Questions and answers
- Which oncology drug tenders in Slovakia are open now?
- None is open at the moment; GranTender lists 55 in total.
- Where can I find oncology drug tenders in Slovakia?
- GranTender lists them in one place, from Centrálny register zmlúv and TED, with their buyers, winners and contract values; 0 are open now. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
- Who wins the most oncology drug tenders in Slovakia?
- By number of contracts won: MED - ART, spol. s r.o. (95), UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť (49), BAX PHARMA, s.r.o. (20).
- Which buyers publish the most oncology drug tenders in Slovakia?
- By number of tenders: Všeobecná zdravotná poisťovňa, a. s. (15), Fakultná nemocnica s poliklinikou Žilina (13), Národný ústav reumatických chorôb (5).
- Which CPV codes belong to “Oncology and immunomodulating drugs”?
- 33652000 Antineoplastic and immunomodulating agents; plus tenders without a usable CPV code whose title names the topic.
- How many bids do oncology drug tenders in Slovakia receive on average?
- In 2025, contracts drew 2.1 bids on average (median 2) and 44% drew a single bid — based on 79 contracts with a known number of bids.
- How much are contracts for oncology drug tenders in Slovakia worth?
- In 2025, half of the contracts were worth between €21,000 and €610,000, with a median of €150,000 (74 contracts with a stated awarded value). Compared with 2024, in 2025 the median value fell 12% and the share of single-bid contracts rose from 35% to 44%.
- Which procedures are used for oncology drug tenders in Slovakia?
- The usual procedures: open procedure (96%), negotiation without a call for competition (2%), restricted procedure (2%) — of 55 tenders with a stated procedure.
- Which buyers get few offers in oncology drug tenders in Slovakia?
- Since 1 November 2024, these buyers usually received one or two offers per contract: Univerzitná nemocnica Martin (median 2 bids over 62 contracts), Ústredná Vojenská Nemocnica SNP Ružomberok - Fakultná Nemocnica (median 2 bids over 18 contracts) and Národný Endokrinologický a Diabetologický Ústav N. O. (median 1 bid over 13 contracts). Since 1 November 2024, 36% of the 159 contracts with a known number of bids had a single bid; the median was 2 bids.
CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.